Results 71 to 80 of about 4,160 (239)
Non‐Invasive Prenatal Diagnosis of Haemoglobinopathies: From Concept to Clinical Reality
ABSTRACT Haemoglobinopathies are the most prevalent monogenic disorders worldwide, contributing significantly to childhood morbidity and mortality. Preventive strategies, including carrier screening and prenatal diagnosis, have successfully reduced disease incidence in regions with established programmes.
Irene Leonidou +7 more
wiley +1 more source
Most cases of {alpha}-thalassemia result from large deletions at the {alpha}-globin locus (1). The {alpha}-globin gene cluster contains a tandem array of 2 nearly identical {alpha}-globin genes (HBA; Fig. 1A ) (2).
J Evans (7845878) +8 more
core
ABSTRACT Objective To investigate the association between postpartum haemorrhage (PPH) severity and the subsequent risk of premature ovarian failure (POF), with blood transfusion used as a marker of severe PPH: Design Nationwide population‐based retrospective cohort study. Setting Korean National Health Insurance Service (KNHIS) database.
Min‐A Kim +5 more
wiley +1 more source
Prenatal diagnosis of alpha and beta thalassemias and hemophilia A: Experience in Hong Kong
Methods and strategies are described for the prenatal diagnosis of three common congenital disorders - alpha and beta thalassemias and hemophilia A.
Chan, V, Vivian Chan
core +1 more source
Clinical Complications and Their Management [PDF]
The hallmarks of thalassemias are ineffective erythropoiesis and peripheral hemolysis leading to a cascade of events responsible for several clinical complications.
Marcon, Alessia +11 more
core +1 more source
Off‐Label use of a lumen‐apposing metal stent for refractory pyloric stricture in a toddler
JPGN Reports, EarlyView.
Hamza Hassan Khan +2 more
wiley +1 more source
Summary Lack of response or delayed response to therapy are major challenges in the use of DNA‐hypomethylating agents (HMA) in patients with acute myeloid leukaemia (AML). Fetal haemoglobin (HbF) is a potential biomarker for response to HMA treatment but has only been studied in small single‐centre studies.
Julia Stomper +27 more
wiley +1 more source
Gene Editing for Haemophilia—The Next Frontier
ABSTRACT The recently approved haemophilia A and B gene therapies via adeno‐associated virus (AAV) showed a promising therapeutic response after a single injection, but there are still limitations, including the potential loss of transgene expression and restriction in adults.
Mirko Pinotti +3 more
wiley +1 more source
Thalassemia and hypercoagulability
Abstract Although the management of β-thalassemia has improved significantly, patients still suffer from many complications, including thrombotic events. A hypercoagulable state has been demonstrated in these conditions, particularly in non–transfusion-dependent β-thalassemia, because of disease-specific contributors that play a role ...
Cappellini M. D., Taher A. T., Motta I.
openaire +2 more sources
Globin gene regulation for treating β-thalassemias: Progress, obstacles and future [PDF]
Introduction: β-thalassemias result from mutations in the β-globin gene, leading to a reduced or absent production of β-globin chains. The treatment of β-thalassemias has been historically based on blood transfusions and iron chelation therapy.
Alameddine, Raafat S. +3 more
core +1 more source

